Fundraising Fox

BioClin Therapeutics

San Leandro, US · Founded 2010 · Delaware corporation

Biotech

Founders & leadership

SA
Steve AbellaChief Medical Officer
GC
Graeme CurrieChief Operating Officer
SW
Stephen W. LauPresident, Chief Executive Officer, and Treasurer
MS
Marten SteenNamed on SEC filing
CR
Christian RichardNamed on SEC filing
JJ
Joel Jean-MairetNamed on SEC filing
FA
Fouad AzzamNamed on SEC filing
JL
Joseph L. TurnerNamed on SEC filing
DK
David KabakoffNamed on SEC filing
JN
Jack NielsenNamed on SEC filing
KS
Kenneth SchwartzNamed on SEC filing
SL
Stephen LauNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$86M disclosed across 5 rounds · 2012–2019

▶$10MraisedJul 2019 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Graeme CurrieExecutive Officer
  • Julie M. EastlandExecutive Officer
  • David KabakoffDirector
  • Joel Jean-MairetDirector
  • Christian RichardDirector
  • Fouad AzzamDirector
  • Marten SteenDirector
  • Joseph L. TurnerDirector
  • Scott D. MyersExecutive Officer, Director
  • Steve AbellaExecutive Officer
Offering amount
$19.2M
Amount sold
$10M
First sale
Jul 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedFeb 2019 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David KabakoffDirector
  • Marten SteenDirector
  • Christian RichardDirector
  • Graeme CurrieExecutive Officer
  • Julie M. EastlandExecutive Officer
  • Fouad AzzamDirector
  • Scott D. MyersExecutive Officer, Director
  • Joseph L. TurnerDirector
  • Joel Jean-MairetDirector
  • Steve AbellaExecutive Officer
Offering amount
$20M
Amount sold
$10M
First sale
Jan 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50MraisedMay 2018 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marten SteenDirector
  • Christian RichardDirector
  • Joel Jean-MairetDirector
  • Steve AbellaExecutive Officer
  • Fouad AzzamDirector
  • Joseph L. TurnerDirector
  • Graeme CurrieExecutive Officer
  • David KabakoffDirector
  • Stephen W. LauExecutive Officer, Director
Offering amount
$50M
Amount sold
$50M
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedJun 2014 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph L. TurnerDirector
  • Thomas BooneDirector
  • Stephen LauExecutive Officer, Director
Offering amount
$10M
Amount sold
$10M
First sale
Dec 2012
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedApr 2014 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jack NielsenDirector
  • Kenneth SchwartzExecutive Officer
  • Joseph L. TurnerDirector
  • Stephen LauExecutive Officer, Director
  • Eric YuenExecutive Officer
  • Martin SteenDirector
  • Peter MoldtDirector
Offering amount
$6M
Amount sold
$6M
First sale
Apr 2014
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has BioClin Therapeutics raised?
BioClin Therapeutics has disclosed $86M raised across 5 rounds.
Where is BioClin Therapeutics headquartered?
BioClin Therapeutics is headquartered in San Leandro, US.